09 Mar 2007


The Eu5.7bn facility for pharmaceutical group Nycomed, which is buying German rival Altana, has closed. The deal was finally oversubscribed after the bookrunners Credit Suisse, Citigroup, Goldman Sachs and Morgan Stanley and mandated lead arrangers Nordea, SEB Merchant Banking and DnB NOR flexed the deal to include a ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.